“…Furthermore, with single-cell multimodal omics being selected as the Methods of the Year 2019 ( Nature Methods, 2020 ), techniques for simultaneous measuring multiple modalities in the same single cells are blooming rapidly. Related to epigenomics, it has become possible to simultaneous profile accessible chromatin and transcriptome ( Cao et al, 2018 ; Chen et al, 2019 ; Li et al, 2019 ; Moudgil et al, 2020 ), methylome and transcriptome ( Angermueller et al, 2016 ), methylome and chromatin conformation ( Li et al, 2019 ), or even three modalities altogether ( Pott, 2017 ; Clark et al, 2018 ) within the same cells. The combinatorial use of single-cell epigenomics techniques on cardiac samples will potentially provide a holistic view of enhancer activities in all subtypes of cardiac cells across all stages in heart development.…”